Associated Papers
Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson's disease risk.
Chew EG et al.
Nature Aging, 2025
39572736 (PubMed )
Supplement: 43587_2024_760_MOESM3_ESM.xlsx › Supplementary_Table_9
Insights into the Value of Lyso-Gb1 as a Predictive Biomarker in Treatment-Naïve Patients with Gaucher Disease Type 1 in the LYSO-PROOF Study.
Curado F et al.
Diagnostics (basel, Switzerland), 2023
37685353 (PubMed )
Supplement: diagnostics-13-02812-s001.zip › diagnostics-2530284-supplementary.pdf
[The molecular genetic diagnostic of Gaucher disease type I].
Lukina KA et al.
Klinicheskaia Laboratornaia Diagnostika, 2014
Persistent tryptase elevation in a patient with Gaucher disease.
Schussler E et al.
The Journal of Allergy and Clinical Immunology. in Practice, 0
Select a paper to view details